99mTc bone scintigraphy superscans: a review
Authors:
- Orla BuckleyOBOrla Buckley
- Sylvia O'KEeffeSOSylvia O'KEeffe
- Tony GeogheganTGTony Geoghegan
- Ian D. LyburnILIan D. Lyburn
- Peter L. MunkPMPeter L. Munk
- Dan WorsleyDWDan Worsley
- William C. TorreggianiWTWilliam C. Torreggiani
- 1 July 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 28 (7) , 521-527
Abstract
Whole-body bone scintigraphy (bone scan) using a (99m)Tc-labelled pharmaceutical is one of the most commonly performed radionuclide examinations. In the normal patient, both the osseous components of the skeletal system as well as the kidneys and bladder are visualized. A superscan is defined as a bone scan which demonstrates markedly increased skeletal radioisotope uptake relative to soft tissues, in association with absent or faint genito-urinary tract activity. While a superscan is relatively uncommon, its recognition is important, as it is associated with a number of important underlying diseases. The purpose of this review article is to describe the causes and variable features of a superscan and depict patterns which may aid in defining the underlying cause for the scan. In addition, we will discuss other investigations that may help further to identify the underlying disease in such cases.Keywords
This publication has 33 references indexed in Scilit:
- F-18 FDG PET SuperscanClinical Nuclear Medicine, 2006
- 99Tcm(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implicationsBritish Journal of Radiology, 2004
- Super Scan Leading to Definitive Diagnosis in a Patient With Recurrent SyncopeClinical Nuclear Medicine, 2003
- Evaluation of Bone Metastases by Tc-99m MDP Imaging in Patients With Stomach CancerClinical Nuclear Medicine, 1995
- Antigranulocyte Antibody Bone Marrow Scans in Cancer Patients With Metastatic Bone Superscan AppearanceClinical Nuclear Medicine, 1994
- Absent or Faint Renal Uptake on Bone ScanClinical Nuclear Medicine, 1991
- Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: Dependency on age, sex and glomerular filtrationScandinavian Journal of Clinical and Laboratory Investigation, 1984
- Recognition of the superscan in prostatic bone scintigraphyBritish Journal of Radiology, 1981
- Myelofibrosis Presenting as Hypermetabolic Bone Disease by Radionuciide Imaging in a Patient with AspleniaClinical Nuclear Medicine, 1978
- Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophyBritish Journal of Radiology, 1975